EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Seroprevalence of Hepatitis B Core IgM Antibodies Among Apparently Healthy Blood Donors: An Enzyme Immunoassay-Based Cross-Sectional Study

Devendra Singh, Navneet Kumar

Adolescência e Saúde · 10.06.2026 · 21 (3s) · 759-764

DOI: 10.67440/ahj.v21i3s.1260 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Adolescência e Saúde, online erschienen am 10.06.2026. Verfasst von Devendra Singh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives: Hepatitis B virus (HBV) remains a major transfusion-transmitted infection despite routine screening for hepatitis B surface antigen (HBsAg). The present study aimed to determine the seroprevalence of anti-hepatitis B core immunoglobulin M (anti-HBc IgM) antibodies among HBsAg-non-reactive blood donors using ELISA.

Methods

In this prospective cross-sectional study, 115 apparently healthy HBsAg-non-reactive blood donors were recruited from a tertiary care blood centre in Moradabad, Uttar Pradesh, India. Donor demographic and clinical characteristics were recorded. Serum samples were screened for anti-HBc IgM antibodies using a commercially available ELISA kit according to the manufacturer's instructions. Descriptive statistics were used to summarize the study findings.

Results

The mean age of the donors was 33.2 ± 7.0 years, and 97.4% were male. Blood group A (39.1%) was the most frequent ABO type, while 94.8% of donors were Rh positive. Anti-HBc IgM antibodies were detected in 9 of 115 HBsAg-non-reactive donors, yielding a seroprevalence of 7.8%, whereas 106 (92.2%) donors were non-reactive. conclusions: Detection of anti-HBc IgM antibodies among HBsAg-non-reactive blood donors suggests that exclusive HBsAg screening may not identify all potentially infectious donations. Supplementary serological screening may improve blood transfusion safety, particularly in settings where nucleic acid testing is not routinely available.

Zitieren

APA

Singh, D., & Kumar, N. (2026). Seroprevalence of Hepatitis B Core IgM Antibodies Among Apparently Healthy Blood Donors: An Enzyme Immunoassay-Based Cross-Sectional Study. Adolescência e Saúde, 21(3s), 759-764. https://doi.org/10.67440/ahj.v21i3s.1260

Vancouver

Singh D, Kumar N. Seroprevalence of Hepatitis B Core IgM Antibodies Among Apparently Healthy Blood Donors: An Enzyme Immunoassay-Based Cross-Sectional Study. Adolescência e Saúde. 2026;21(3s):759-764. doi:10.67440/ahj.v21i3s.1260

BibTeX
@article{Singh2026,
  author = {Singh, Devendra and Kumar, Navneet},
  title = {Seroprevalence of Hepatitis B Core IgM Antibodies Among Apparently Healthy Blood Donors: An Enzyme Immunoassay-Based Cross-Sectional Study},
  journal = {Adolescência e Saúde},
  year = {2026},
  volume = {21},
  number = {3s},
  pages = {759--764},
  doi = {10.67440/ahj.v21i3s.1260}
}
Kostenlos starten →